‘Pharma bro’ Martin Shkreli has already found himself back in the spotlight of the law, less than a year after being released from prison for securities fraud.
Given that Martin Shkreli has a lifetime restraining order preventing him from working in the pharma industry, it will raise a few eyebrows that his new company – launched just two months a
Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving AIDS drug by around 5,000%, has been released early from his seven-year prison term for de
The man who sent the price of lifesaving drug Daraprim (pyrimethamine) rocketing from $13.50 a tablet to $750 overnight has been ordered to repay $64.6m (£47m).
A pharma company formerly led by 'pharma bro' Martin Shkreli has settled a long-running lawsuit with the US federal government over massive price increases for an off-patent drug treatment
The US government has sold off the one-of-a-kind Wu-Tang Clan album famously bought by 'pharma bro' Martin Shkreli, with the proceeds enough to wipe out his $7.4 million fine for defrauding
MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio